TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease

Seyedeh M. Zekavat(Broad Institute), Derek Klarin(Stanford University), Alexander G. Bick(Vanderbilt University Medical Center), Nuria Matesanz(Spanish National Centre for Cardiovascular Research), James P. Pirruccello(University of California, San Francisco), Alba Ferrer-Pérez(Spanish National Centre for Cardiovascular Research), Mark Trinder(Broad Institute), Marta Amorós-Pérez(MACOM (United States)), Vanesa Viana‐Huete(Spanish National Centre for Cardiovascular Research), Abhishek Niroula(Broad Institute), Peter Libby(Harvard University), Pradeep Natarajan(Unknown), Christopher J. Gibson(Otsuka (Japan)), Christie M. Ballantyne(Baylor College of Medicine), Alejandra Aroca-Crevillén(Spanish National Centre for Cardiovascular Research), Kaavya Paruchuri(Broad Institute), Roberta Carriero(IRCCS Humanitas Research Hospital), Marzyeh Ghassemi(Vector Institute), Benjamin L. Ebert(Dana-Farber Cancer Institute), Valentı́n Fuster(Mount Sinai Hospital), Hongyu Zhao(Yale University), Saman Doroodgar Jorshery(Gordon Center for Medical Imaging), Scott M. Damrauer(Philadelphia VA Medical Center), María A. Zuriaga(Spanish National Centre for Cardiovascular Research), Andrés Hidalgo(Spanish National Centre for Cardiovascular Research), José J. Fuster(Spanish National Centre for Cardiovascular Research), Carolina M. Greco(Humanitas University), Paolo Kunderfranco(IRCCS Humanitas Research Hospital), Virginia Zorita(Spanish National Centre for Cardiovascular Research), Gabriel K. Griffin(Brigham and Women's Hospital), Md Mesbah Uddin(Broad Institute)
Nature Cardiovascular Research
January 16, 2023
Cited by 135


Related Papers